ldl size and coronary risk predictive value of ldl-particle size physicians ’ health study
DESCRIPTION
LDL Size and Coronary Risk Predictive value of LDL-particle size Physicians ’ Health Study. Relative Risk of M I. * Adjusted RR for total/HDL-cholesterol, plasma apo B level, BMI, diabetes, hypertension, angina and excercice level. At 95 % CI (1.30 - 7.76). 3.18*. 1. - PowerPoint PPT PresentationTRANSCRIPT
LDL Size and Coronary RiskPredictive value of LDL-particle size
Physicians ’ Health Study
Relative Riskof M I
Quintile of LDL diameter
Q1
(222 - 250 Å)
Q5
(266 - 278 Å)
3.18*
1
* Adjusted RR for total/HDL-cholesterol, plasma apo B level, BMI, diabetes, hypertension, angina and excercice level. At 95 % CI (1.30 - 7.76)
Les Dyslipidémies
• Hyperlipidémies combinées Chol TG
• Déséquilibre entre LDL-Chol et HDL-Chol
• Sous-fractions de LDL particulièrement athérogènes
• Sous-fractions de HDL peu protectrices
• Modifications des apolipoprotéines (adducts, AGE, ALE)
du risque, même pour des concentrations
plasmatiques non (ou modérément) augmentées
ACTIONS OF STATINS
S = sous statine; P = sous placeboKastelein JJP. Atherosclerosis 1999; 143(suppl 1): S17-S21
LDL-C, mg/dl
% a
vec
acc
iden
t co
ron
arie
nTaux de LDL-C vs accidents coronariens dans
les principales études sur les statines
25
20
15
10
5
0
90 110 130 150 170 190 210
4S-P
CARE-P
LIPID-P4S-S
WOSCOPS-S
WOSCOPS-P
AFCAPS-P
AFCAPS-S
LIPID-S
CARE-S
Prévention secondaire
Prévention primaire
Simvastatine
Pravastatine
Lovastatine
hs-
CR
P (
mg
/L)
Effect of Statin Therapy on hs-CRP Levels at 6 Weeks
Jialal I et al. Circulation 2001;103:1933-1935.
6
5
4
3
2
1
0Baseline
* * *
Prava(40 mg/d)
Simva(20 mg/d)
Atorva(10 mg/d)
*p<0.025 vs. Baseline